Wilson H. Miller - Researcher Profile

Publications

2 shown

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert , L. Thomas , Igor Bondarenko +21 more

Ipilimumab (at a dose of 10 mg per kilogram) in combination with dacarbazine, as compared with dacarbazine plus placebo, improved overall survival in patients with previously un...

2011 New England Journal of Medicine 4405 citations

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S. Weber , Sandra P. D’Angelo , David R. Minor +25 more

2015 The Lancet Oncology 2617 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,022
Institution: Jewish General Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7408-1574

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.